In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration

Gynecologic Oncology

Volumn 61, Issue 2, 1996, Pages 175-179

  Tong, X W ^a   Block, A ^a   Chen, S H ^a   Contant, C F ^a   Agoulnik, I ^a   Blankenburg, K ^a   Kaufman, R H ^a   Woo, S L C ^a   Kieback, D G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL;

EID: 0029866724     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0121     Document Type: Article

References (19)

1. McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., and Davidson, M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer, N. Engl. J. Med. 334, 1-6 (1996).
2. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo, Proc. Natl. Acad. Sci. USA 91, 3054-3057 (1994).
3. Chen, S. H., Chen, X. H., Wang, Y., Kosai, K., Finegold, M. J., Rich, S. S., and Woo, S. L. Combination gene therapy for liver metastasis of colon carcinoma in vivo, Proc. Natl. Acad. Sci. USA 92, 2577-2581 (1995).
4. Ezzeddine, Z. T., Martuza, R. A., Platika, D., Short, M. P. P., Malick, A., Choi, B., and Breakefield, X. O. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase, New Biol. 3, 608-614 (1991).
5. Freeman, S. M., Whartenby, K. A., Koeplin, D. S., Moolten, F. L., Abboud, C. N., and Abraham, G. N. Tumor regression when a fraction of tumor mass contains the HSV-TK gene, J. Cell Biochem. 16F, 47 (1992).
6. Freeman, S. M., McCune, C., Robinson, W., Abboud, C. N., Abraham, G. N., Angel, C., and Marrogi, A. The treatment of ovarian cancer with a gene modified cancer vaccine: A phase I study, Hum. Gene Ther. 6, 927-939 (1995).
7. Oldfield, E. H., Ram, Z., Culver, K. W., Blaese, R. M., DeVroom, H. L., and Anderson, W. F. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir, Hum. Gene Ther. 4, 39-69 (1993).
8. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes simplex virus thymidine kinase gene, J. Natl. Cancer. Inst. 82, 297-300 (1990).
9. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumor, Science 256, 1550-1552 (1992).
10. Ram, Z., Culver, K. W., Walbridge, R., Blaese, R. M., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats, Cancer Res. 53, 83-88 (1993).
11. Cheng, Y. C., Grill, S. P., Dutschman, G. E., Nakayama, K., and Bastow, K. F. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes simplex virus compound, in herpes simplex virus-infected cells, J. Biol. Chem. 258, 12460-12464 (1983).
12. O'Malley, B. W. J., Chen, S. H., Schwartz, M. R., and Woo, S. L. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model, Cancer Res. 55, 1080-1085 (1995).
13. Perez-Cruet, M. J., Trask, T. W., Chen, S. H., Goodman, J. C., Woo, S. L., Grossman, R. G., and Shine, H. D. Adenovirus-mediated gene therapy of experimental gliomas, J. Neurosci. Res. 39, 506-511 (1994).
14. Neve, R. L. Adenovirus vectors enter the brain, Trends Neurosci. 16, 251-253 (1993).
15. Zhang, Y., Yu, D., Xia, W., and Hung, M. C. HER-2/neu-targeting cancer therapy via adenovirus-mediated EIA delivery in an animal model, Oncogene 10, 1947-1954 (1995).
16. Tong, X.-W., Block, A., Chen, S.-H., Woo, S. L. C., and Kieback, D. G. Adenovirus-mediated thymidine kinase gene transduction of human epithelial ovarian cancer cell lines followed by exposure to ganciclovir, Anticancer Res., in press (1996).
17. Bonnekoh, B., Greenhalgh, D. A., Bundman, D. S., Eckhardt, J. N., Longley, M. A., Chen, S. H., Woo, S. L., and Roop, D. R. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo, J. Invest. Dermatol. 104, 313-317 (1995).
18. Freemann, S. M., McCune, C., Angel, C., Abraham, G. N., and Abbound, C. N. Treatment of ovarian cancer using HSV-TK gene modified vaccine-regulatory issues, Hum. Gene Ther. 3, 342-349 (1992).
19. Fujita, K., Ikarashi, H. K., Kodama, S., Akagi, T., Yamamoto, T., and Tanaka, K. Enhancement of T cell receptor signaling of tumor-infiltrating lymphocytes by retrovirally mediated fyn gene transduction, Jap. J. Cancer Res. 85, 1073-1079 (1994).